← EU FEED

Avalo Therapeutics Purchases Optional Milestone Buyout

AI BRIEFING

  • Avalo Therapeutics enters into milestone buyout option agreement with AlmataBio.
  • The agreement is related to the company's prior acquisition of AlmataBio in March 2024.
  • Details of the agreement were not disclosed.
ADVERTISEMENT
READ ORIGINAL ARTICLE